143 related articles for article (PubMed ID: 31089872)
1. Ocular alterations, molecular findings, and three novel pathological mutations in a series of NF2 patients.
Waisberg V; Rodrigues LOC; Nehemy MB; Bastos-Rodrigues L; de Miranda DM
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1453-1458. PubMed ID: 31089872
[TBL] [Abstract][Full Text] [Related]
2. Spectral-Domain Optical Coherence Tomography Findings in Neurofibromatosis Type 2.
Waisberg V; Rodrigues LO; Nehemy MB; Frasson M; de Miranda DM
Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT262-7. PubMed ID: 27409481
[TBL] [Abstract][Full Text] [Related]
3. [Retinal Astrocytic Hamartoma in Neurofibromatosis Type 2 - Metaanalysis and a Case Report].
Starosta DA; Lorenz B
Klin Monbl Augenheilkd; 2018 Mar; 235(3):290-300. PubMed ID: 29534265
[TBL] [Abstract][Full Text] [Related]
4. Neurofibromatosis Type 2-Related Eye Disease Correlated With Genetic Severity Type.
Painter SL; Sipkova Z; Emmanouil B; Halliday D; Parry A; Elston JS
J Neuroophthalmol; 2019 Mar; 39(1):44-49. PubMed ID: 29923868
[TBL] [Abstract][Full Text] [Related]
5. Neurofibromatosis 2 leads to choroidal hyperfluorescence in fluorescein angiography.
Feucht M; Richard G; Mautner VF
Graefes Arch Clin Exp Ophthalmol; 2007 Jul; 245(7):949-53. PubMed ID: 17186263
[TBL] [Abstract][Full Text] [Related]
6. Structural Abnormalities of the Central Retina in Neurofibromatosis Type 2.
Emmanouil B; Wasik M; Charbel Issa P; Halliday D; Parry A; Sharma SM
Ophthalmic Res; 2022; 65(1):77-85. PubMed ID: 34673638
[TBL] [Abstract][Full Text] [Related]
7. Combined retinal hamartomas leading to the diagnosis of neurofibromatosis type 2.
Grant EA; Trzupek KM; Reiss J; Crow K; Messiaen L; Weleber RG
Ophthalmic Genet; 2008 Sep; 29(3):133-8. PubMed ID: 18766994
[TBL] [Abstract][Full Text] [Related]
8. Retinal dystrophy and subretinal drusenoid deposits in female choroideremia carriers.
Murro V; Mucciolo DP; Passerini I; Palchetti S; Sodi A; Virgili G; Rizzo S
Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2099-2111. PubMed ID: 28752371
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of sporadic neurofibromatosis type 2 in the paediatric population.
Anand G; Vasallo G; Spanou M; Thomas S; Pike M; Kariyawasam DS; Mehta S; Parry A; Durie-Gair J; Nicholson J; Lascelles K; Everett V; Gibbon FM; Jarvis N; Elston J; Evans DG; Halliday D
Arch Dis Child; 2018 May; 103(5):463-469. PubMed ID: 29535107
[TBL] [Abstract][Full Text] [Related]
10. [Phenotype-genotype study in 154 French NF2 mutation carriers].
Demange L; De Moncuit C; Thomas G; Olschwang S
Rev Neurol (Paris); 2007 Nov; 163(11):1031-8. PubMed ID: 18033041
[TBL] [Abstract][Full Text] [Related]
11. Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease.
Ruttledge MH; Andermann AA; Phelan CM; Claudio JO; Han FY; Chretien N; Rangaratnam S; MacCollin M; Short P; Parry D; Michels V; Riccardi VM; Weksberg R; Kitamura K; Bradburn JM; Hall BD; Propping P; Rouleau GA
Am J Hum Genet; 1996 Aug; 59(2):331-42. PubMed ID: 8755919
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetic analysis of the NF2 gene in young patients with unilateral vestibular schwannomas.
Mohyuddin A; Neary WJ; Wallace A; Wu CL; Purcell S; Reid H; Ramsden RT; Read A; Black G; Evans DG
J Med Genet; 2002 May; 39(5):315-22. PubMed ID: 12011146
[TBL] [Abstract][Full Text] [Related]
13. Autosomal recessive bestrophinopathy: differential diagnosis and treatment options.
Boon CJ; van den Born LI; Visser L; Keunen JE; Bergen AA; Booij JC; Riemslag FC; Florijn RJ; van Schooneveld MJ
Ophthalmology; 2013 Apr; 120(4):809-20. PubMed ID: 23290749
[TBL] [Abstract][Full Text] [Related]
14. Correlation of nonsense and frameshift mutations with severity of retinal abnormalities in neurofibromatosis 2.
Feucht M; Kluwe L; Mautner VF; Richard G
Arch Ophthalmol; 2008 Oct; 126(10):1376-80. PubMed ID: 18852415
[TBL] [Abstract][Full Text] [Related]
15. Neurofibromatosis 2 leads to higher incidence of strabismological and neuro-ophthalmological disorders.
Feucht M; Griffiths B; Niemüller I; Haase W; Richard G; Mautner VF
Acta Ophthalmol; 2008 Dec; 86(8):882-6. PubMed ID: 18976311
[TBL] [Abstract][Full Text] [Related]
16. Clinical and genetic characteristics of Leber congenital amaurosis with novel mutations in known genes based on a Chinese eastern coast Han population.
Wang S; Zhang Q; Zhang X; Wang Z; Zhao P
Graefes Arch Clin Exp Ophthalmol; 2016 Nov; 254(11):2227-2238. PubMed ID: 27422788
[TBL] [Abstract][Full Text] [Related]
17. Ophthalmic features of cone-rod dystrophy caused by pathogenic variants in the ALMS1 gene.
Nasser F; Weisschuh N; Maffei P; Milan G; Heller C; Zrenner E; Kohl S; Kuehlewein L
Acta Ophthalmol; 2018 Jun; 96(4):e445-e454. PubMed ID: 29193673
[TBL] [Abstract][Full Text] [Related]
18. NF2 genetic alterations in sporadic vestibular schwannomas: clinical implications.
Lassaletta L; Torres-Martín M; Peña-Granero C; Roda JM; Santa-Cruz-Ruiz S; Castresana JS; Gavilan J; Rey JA
Otol Neurotol; 2013 Sep; 34(7):1355-61. PubMed ID: 23921927
[TBL] [Abstract][Full Text] [Related]
19. Identification of NF2 germ-line mutations and comparison with neurofibromatosis 2 phenotypes.
Kluwe L; Bayer S; Baser ME; Hazim W; Haase W; Fünsterer C; Mautner VF
Hum Genet; 1996 Nov; 98(5):534-8. PubMed ID: 8882871
[TBL] [Abstract][Full Text] [Related]
20. Targeted deep sequencing of DNA from multiple tissue types improves the diagnostic rate and reveals a highly diverse phenotype of mosaic neurofibromatosis type 2.
Teranishi Y; Miyawaki S; Hongo H; Dofuku S; Okano A; Takayanagi S; Ota T; Yoshimura J; Qu W; Mitsui J; Nakatomi H; Morishita S; Tsuji S; Saito N
J Med Genet; 2021 Oct; 58(10):701-711. PubMed ID: 33067351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
